Scribe Therapeutics, Inc. Increase (Decrease) in Accounts Receivable
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-09-02
- 2026-06-30: Increase (Decrease) in Accounts Receivable 6 month -$5.99M.
- 2025-06-30: Increase (Decrease) in Accounts Receivable 6 month -$292.00K.
| Period end | Increase (Decrease) in Accounts Receivable 6 month |
|---|---|
| 2026-06-30 | -$5.99M 10-Q · filed 2026-09-02 |
| 2025-06-30 | -$292.00K 10-Q · filed 2026-09-02 |